tirzepatide for psoriasis Plus Ixekizumab Signals Early Anti-Inflammatory Benefit in Psoriatic Disease Mark Lebwohl, MD | Authors
Description
It is the first approved drug of its class, a so-called twincretin
Conversely, some individuals who initially tolerated high doses find that after substantial weight loss, lower doses provide adequate maintenance with fewer side effects
Its a poor fit if: You have primary hypogonadism high LH/FSH alongside low T means your testes cant respond to stimulation
But some people also report no effect whatsoever
If you have a specific requirement, please let us know
